Recent Updates
Recently added Catalysts
INDV Positive Sentiment Score: 70/100

Indivior To Participate in Upcoming Investor Events Slough, UK, and Richmond, VA

Wednesday, September 6, 2023 2 min read
Key Takeaway: Indivior PLC announced its participation in upcoming investor events in Slough, UK, and Richmond, VA. CEO Mark Crossley and CFO Ryan Preblick will host meetings and participate in fireside chats on September 11th and September 22nd respectively. The events will be accessible to interested investors, showcasing Indivior's dedication to transparency and investor relations. The company focuses on developing treatments for addiction and serious mental illnesses.

Market Sentiment Analysis

POSITIVE FACTORS

  • Indivior is actively engaging with investors through planned events.
  • Participation in fireside chats indicates transparency and openness.
  • Indivior is recognized for its commitment to treating addiction and mental illnesses.

Full Press Release Details

Indivior To Participate in Upcoming Investor Events
Slough, UK, and Richmond, VA, September 6, 2023 Indivior PLC (LSE/NASDAQ: INDV) today announced that it will participate in
the following investor events:
Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host
1x1 / group meetings on Monday, September 11th. Mark Crossley will participate in a fireside chat at 10:40 a.m. US EDT. Interested investors should contact their Morgan Stanley representative to
schedule a meeting. The fireside chat will be publicly available and can be viewed using the following weblink:
Mark Crossley, Chief Executive Officer, will participate in a fireside chat on Friday, September 22nd at 14:00 BST (9:00 a.m. US EST). The fireside chat will be publicly available and can be viewed using the following weblink:
Both events will also be
accessible at www.indivior.com under the Investors section.
Indivior is a global pharmaceutical company working to help change patients lives by developing medicines to treat addiction and serious mental
illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of substance use disorder (SUD). Indivior is
dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this
category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA,
Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/indivior.
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com

Frequently Asked Questions

What events will Indivior participate in?

Indivior will participate in investor events including 1x1/group meetings and fireside chats.

Who will host the investor meetings?

Mark Crossley, the CEO, and Ryan Preblick, the CFO, will host the meetings.

When is the first fireside chat scheduled?

The first fireside chat is on September 11th at 10:40 a.m. US EDT.

Where can I view the fireside chats?

Fireside chats can be viewed on Indivior's website under the Investors section.

What is Indivior's main focus?

Indivior focuses on developing medicines for addiction and serious mental illnesses.

Tags: INDV Viatris Investor Conferences Healthcare Indivior investor events addiction treatment mental illnesses Richmond VA
Last updated: Sep 6, 2023